432 / 1631
Size of the problem
•
Primary refractory :
~10% of de novo cHL
•
Relapse:
•
Limited stage: 5 – 15%
•
Advanced stage: 20 – 40%
•
Salvage HD-CT + AutoSCT:
50% success
|
|
432 / 1631
Size of the problem
•
Primary refractory :
~10% of de novo cHL
•
Relapse:
•
Limited stage: 5 – 15%
•
Advanced stage: 20 – 40%
•
Salvage HD-CT + AutoSCT:
50% success